<DOC>
	<DOCNO>NCT01016626</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerance compare pharmacokinetic characteristic CKD-4101 tablet Mycophenolate mofetil capsule administer alone healthy volunteer .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetic Characteristics CKD-4101 ( Mycophenolate Mofetil ) Tablet</brief_title>
	<detailed_description>Healthy volunteer administrate single-dose period I II ( Crossover ) CKD-4101 1000mg Mycophenolate mofetil capsule 1000mg . Every time medication , PK parameter safety CKD-4101 tablet Mycophenolate mofetil capsule perform use blood sample conduct test respectively .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Between 20 age 45 age healthy male Weight 45 kg , IBW ± 20 % within range Ideal body weight = ( Height cm 100 ) x 0.9 Agreement write informed consent Subject symptoms acute disease within 28 day start administration investigational drug Subject know history ( inflammatory gastrointestinal disease , gastric duodenal ulcer , liver disease ) affect ADME drug Clinically significant , active gastrointestinal system , cardiovascular system , pulmonary system , renal system , Blood system , digestive system , central nervous system , mental disease malignancy disease . Inadequate subject medical examination ( medical history , physical examination , ECG , laboratory test ) within 28 day start administration investigational drug Inadequate result laboratory test AST ALT &gt; 1.25 x upper limit normal range Total bilirubin &gt; 1.25 x upper limit normal range Abnormal level WBC , Platelet , Hemoglobin WBC &lt; 3.5 x 1000/µL PLT &lt; 100 x 1000/µL Hemoglobin &lt; 11g/dL Clinically significant allergic disease ( Except mild allergic rhinitis seem need medication ) HGPRT ( Hypoxanthineguanine phosphoribosyltransferase ) deficiency patient LeschNyhan syndrome kelleySeegmiller syndrome Severe renal dysfunction : Creatinine clearance le 50ml/min cockroftGault calculation Subject know hypersensitivity reaction mycophenolic acid mycophenolate mofetil analog Previously participate trial within 60 day Treatment dugmedicated induction/inhibition metabolic enzyme barbiturate within 1month may affect clinical trial within 10 day Unusual diet may affect ADME drug Not able take institutional standard meal Previously make whole blood donation within 60 day component blood donation within 20 day Continued take caffeine ( caffeine &gt; 5 cup/day ) , drink ( alcohol &gt; 30 g/day ) clinical trial drink severe heavy smoker ( cigarette &gt; 1/2 pack per day ) An impossible one participate clinical trial investigator 's decision include reason laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy volunteer</keyword>
	<keyword>Mycophenolate Mofetil</keyword>
</DOC>